Jeffrey Jonas

Jeffrey Jonas joined SAGE Therapeutics as CEO in 2013 and has more than 20 years of experience on both the scientific and business sides of the pharmaceutical and healthcare industries, particularly in the CNS field. Before joining the SAGE team, Dr. Jonas served as the President of the Regenerative Medicine Division of Shire plc and previously as Senior Vice President of Research and Development, Pharmaceuticals at Shire. He has more than 70 scientific papers and chapters, authored more than 100 books, scientific articles and abstracts, and has received numerous awards.